Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves first-in-class DED drop ➤ FDA accepts NDA for topical presbyopia therapy ➤ TFOS DEWS III ➤ Topline results in Phase 3 study evaluating night driving impairment after keratorefractive surgery ➤ IND application submitted for pediatric myopia treatment ➤ Study sheds light on clinical inherited retinal diseases without genetic mutations ➤ ASCRS news and events
➤ Positive update from Phase 2 study evaluating oligonucleotide for AMD and DME ➤ 18-month data presented on novel drug delivery platform ➤ Phase 1/2a trial results for intravitreal injection for treatment of glaucoma ➤ Advancing AI to facilitate detection and improve management of ocular disease ➤ Fast Track designation granted for neuropathic corneal pain ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy ➤ ASCRS news and events
Steroid-induced glaucoma can present a number of issues, most notably increased IOP. Several ophthalmologists discussed identifying when and why this occurs and how to react to help improve the pressure.
Manjool Shah, MD, gave an overview of the articles in the Glaucoma section, noting, “The insights shared by our contributors serve as a reminder of the importance of continuous learning and adaptation, and there is no place better to feel the energy of lifelong learning like the ASCRS Annual Meeting.”
Pseudoexfoliation syndrome is a systemic, age-related disease, with patients needing more frequent monitoring due to an increased risk of developing secondary open angle glaucoma from the condition. Two physicians provided their perspectives on the condition and advice for its identification, management, and considerations for surgery.
During the COVID-19 pandemic, ophthalmic practices turned to telemedicine to stay in contact with patients and get them the care they needed. In this article, two physicians discussed their experience with telemedicine, including how they saw its applications evolve and thoughts on the future potential of telehealth options.
ASCRS Subspecialty Day will take place on Friday, April 25, ahead of the official kickoff of the main 2025 ASCRS Annual Meeting. This year, attendees can expect exciting programs focusing on refractive, cornea, and glaucoma topics. The program chairs discussed what they’re looking forward to.